New Trends in Regenerative Medicine: Reprogramming and Reconditioning.
作者信息
Goligorsky Michael S
机构信息
Departments of Medicine,
Pharmacology, and.
出版信息
J Am Soc Nephrol. 2019 Nov;30(11):2047-2051. doi: 10.1681/ASN.2019070722. Epub 2019 Sep 20.
Abstract
摘要
相似文献
1
New Trends in Regenerative Medicine: Reprogramming and Reconditioning.再生医学的新趋势：重编程与重塑
J Am Soc Nephrol. 2019 Nov;30(11):2047-2051. doi: 10.1681/ASN.2019070722. Epub 2019 Sep 20.
2
Elixir of Life: Thwarting Aging With Regenerative Reprogramming.长生不老药：通过再生重编程来对抗衰老。
Circ Res. 2018 Jan 5;122(1):128-141. doi: 10.1161/CIRCRESAHA.117.311866.
3
Programming and reprogramming a human heart cell.对人类心脏细胞进行编程和重新编程。
EMBO J. 2015 Mar 12;34(6):710-38. doi: 10.15252/embj.201490563. Epub 2015 Feb 20.
4
Epigenetic reprogramming of cell identity: lessons from development for regenerative medicine.细胞身份的表观遗传重编程：再生医学的发育学启示。
Clin Epigenetics. 2021 Jul 23;13(1):144. doi: 10.1186/s13148-021-01131-4.
5
Direct cardiac reprogramming: A new frontier in heart regeneration.
Semin Cell Dev Biol. 2022 Feb;122:1-2. doi: 10.1016/j.semcdb.2021.09.006. Epub 2021 Sep 15.
6
Reprogramming antitumor immunity.重编程抗肿瘤免疫。
Trends Immunol. 2014 Apr;35(4):178-85. doi: 10.1016/j.it.2014.02.003. Epub 2014 Mar 21.
7
Extreme makeover: converting one cell into another.极端改造：将一种细胞转化为另一种细胞。
Cell Stem Cell. 2008 Oct 9;3(4):382-8. doi: 10.1016/j.stem.2008.09.015.
8
Strategies for heart regeneration: approaches ranging from induced pluripotent stem cells to direct cardiac reprogramming.心脏再生策略：从诱导多能干细胞到直接心脏重编程的方法
Int Heart J. 2015;56(1):1-5. doi: 10.1536/ihj.14-344. Epub 2015 Jan 7.
9
Direct Reprogramming, Epigenetics, and Cardiac Regeneration.直接重编程、表观遗传学和心脏再生。
J Card Fail. 2017 Jul;23(7):552-557. doi: 10.1016/j.cardfail.2017.05.009. Epub 2017 May 18.
10
[Induced pluripotent stem cells: a new paradigm to study human tissues].[诱导多能干细胞：研究人体组织的新范例]
Biol Aujourdhui. 2016;210(1):1-8. doi: 10.1051/jbio/2016013. Epub 2016 Jun 10.
引用本文的文献
1
Extracellular derivatives for bone metabolism.用于骨代谢的细胞外衍生物
J Adv Res. 2024 Dec;66:329-347. doi: 10.1016/j.jare.2024.01.011. Epub 2024 Jan 11.
2
Ways and Means of Cellular Reconditioning for Kidney Regeneration.肾脏再生的细胞修复方法与手段。
Am J Nephrol. 2022;53(2-3):96-107. doi: 10.1159/000522050. Epub 2022 Mar 8.
3
Progressive Reinvention or Destination Lost? Half a Century of Cardiovascular Tissue Engineering.渐进式重塑还是迷失方向？心血管组织工程的半个世纪
Front Cardiovasc Med. 2020 Sep 9;7:159. doi: 10.3389/fcvm.2020.00159. eCollection 2020.
本文引用的文献
1
OVOL2 induces mesenchymal-to-epithelial transition in fibroblasts and enhances cell-state reprogramming towards epithelial lineages.OVOL2 在成纤维细胞中诱导间质向上皮转化，并增强细胞状态向上皮谱系的重编程。
Sci Rep. 2019 Apr 24;9(1):6490. doi: 10.1038/s41598-019-43021-z.
2
mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.T8993G Leigh 综合征成纤维细胞的 mRNA 重编程，用于创建线粒体疾病的诱导多能干细胞模型。
Stem Cells Dev. 2019 Jul 1;28(13):846-859. doi: 10.1089/scd.2019.0045. Epub 2019 May 20.
3
Cellular Senescence in the Kidney.肾脏中的细胞衰老。
J Am Soc Nephrol. 2019 May;30(5):726-736. doi: 10.1681/ASN.2018121251. Epub 2019 Apr 18.
4
Transcriptional trajectories of human kidney injury progression.人类肾损伤进展的转录轨迹。
JCI Insight. 2018 Nov 15;3(22):123151. doi: 10.1172/jci.insight.123151.
5
CXCL12 blockade preferentially regenerates lost podocytes in cortical nephrons by targeting an intrinsic podocyte-progenitor feedback mechanism.CXCL12 阻断通过靶向固有足细胞祖细胞反馈机制优先在皮质肾单位中再生丢失的足细胞。
Kidney Int. 2018 Dec;94(6):1111-1126. doi: 10.1016/j.kint.2018.08.013. Epub 2018 Oct 29.
6
Lung transplantation, reconditioning and regeneration: state of the art and perspectives.肺移植、修复与再生：现状与展望
J Thorac Dis. 2018 Jul;10(Suppl 20):S2423-S2430. doi: 10.21037/jtd.2018.04.151.
7
Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells.表观遗传重编程的分化治疗对肝癌细胞发挥抗肿瘤作用。
Mol Ther. 2018 Jul 5;26(7):1840-1854. doi: 10.1016/j.ymthe.2018.04.018. Epub 2018 Apr 26.
8
Endothelial cell dysfunction and glycocalyx - A vicious circle.内皮细胞功能障碍与糖萼——恶性循环。
Matrix Biol. 2018 Oct;71-72:421-431. doi: 10.1016/j.matbio.2018.01.026. Epub 2018 Feb 1.
9
Repression of Interstitial Identity in Nephron Progenitor Cells by Pax2 Establishes the Nephron-Interstitium Boundary during Kidney Development.Pax2对肾单位祖细胞间质身份的抑制在肾脏发育过程中建立了肾单位-间质边界。
Dev Cell. 2017 May 22;41(4):349-365.e3. doi: 10.1016/j.devcel.2017.04.022.
10
The third path of tubulointerstitial fibrosis: aberrant endothelial secretome.肾小管间质性纤维化的第三条途径：异常的内皮细胞分泌组。
Kidney Int. 2017 Sep;92(3):558-568. doi: 10.1016/j.kint.2017.02.033. Epub 2017 May 3.
Zotero 插件